The Dual Sourcing Approach
How robust is your strategy? Are you prepared for supply chain interruption? In today’s turbulent world, risk mitigation strategies are a must – and having a secondary supplier in place for the manufacturing and packaging of life-saving critical medicines is no longer a ‘nice to have’. It should be an essential part of your strategy in terms of patient health.
sponsored by PCI
Whether they know it or not, patients are heavily reliant on complex supply chains for sometimes life-saving medications – and that’s why good supply chain management has always been important for the industry, particularly in the case of critical medicines. However, the COVID-19 pandemic, natural disasters, the war in Ukraine, disruption in labor through staff shortages, and other events in recent years have emphasized how vulnerable the industry’s supply chains truly are and underlined the crucial importance of robust risk mitigation strategies. In addition, the threat of disruption in the supply of equipment, components, and materials – including raw materials – is also a significant risk.
